Clearpoint Neuro Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +11.8% | -2.3% | -142.5% | – | -29.1% | +87.4% | -31.9% | -194.8% | – | -41.3% | – | |
| – | -2.6% | -2.5% | +19.4% | +6.0% | -10.6% | +12.0% | +18.9% | -10.9% | -2.0% | +12.0% | +2.4% | – | |
| – | +105.0% | -238.5% | – | – | +2.6% | -248.2% | – | -117.8% | – | – | – | – | |
| – | -20.0% | -100.0% | – | – | +2,091.7% | -30.4% | -50.3% | +118.7% | -75.4% | +1,216.3% | -66.8% | – | |
| – | -20.0% | – | – | – | +2,091.7% | -30.4% | -50.3% | +118.7% | – | -159.3% | -66.8% | – | |
| – | -59.3% | +308.1% | – | -121.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +10,256.8% | -99.0% | -6,388.1% | – | -3,781.1% | – | -100.0% | – | -109.4% | – | – | |
| – | – | – | -120.5% | – | – | – | – | -111.3% | – | -220.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.